Company Description
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada.
The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018.
The company was founded in 2016 and is based in Littleton, Colorado.
| Country | United States |
| Founded | 2016 |
| IPO Date | Dec 11, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 262 |
| CEO | R. Huntsman |
Contact Details
Address: 7921 Southpark Plaza, Suite 210 Littleton, Colorado 80120 United States | |
| Phone | 844 672 4357 |
| Website | vivos.com |
Stock Details
| Ticker Symbol | VVOS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.00 |
| CIK Code | 0001716166 |
| CUSIP Number | 92859E108 |
| ISIN Number | US92859E2072 |
| Employer ID | 81-3224056 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| R. Kirk Huntsman | Co-Founder, Chairman of the Board and Chief Executive Officer |
| Bradford K. Amman | Chief Financial Officer, Treasurer and Secretary |
| Todd Huntsman | Co-Founder and Senior Vice President of Product and Technology |
| RaeAnn Byrnes | Co-Founder and Senior Vice President of Events and Clinical Advisory Services |
| Susan McCullough | Co-Founder and Executive Vice President of Operations |
| Dr. Terry Jones | Senior Vice President of Human Resources |
| Nicholas M. DeGennaro | Senior Vice President of Mergers and Acquisition Group |
| Ruth Hembree | Senior Vice President of Practice Services |
| John Ballard | Senior Vice President of Technology |
| Michael E. Bruhn | Executive Vice President of Business Operations Integration |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 17, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Feb 6, 2026 | 8-K | Current Report |
| Jan 20, 2026 | 8-K | Current Report |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 14, 2026 | 424B3 | Prospectus |
| Jan 7, 2026 | EFFECT | Notice of Effectiveness |
| Jan 2, 2026 | POS AM | Post-Effective amendments for registration statement |
| Dec 17, 2025 | 8-K | Current Report |
| Dec 5, 2025 | 8-K | Current Report |
| Nov 19, 2025 | 8-K | Current Report |